Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

2392-39-4

Dexamethasone Sodium Phosphate

2392-39-4
NA

2,5-Dimethylfuran D3

NA
1531-77-7

Dibenzo[b,e]thiepin-11(6H)-one

1531-77-7
552-66-9

Daidzin

552-66-9
1453167-99-1

Dextromethorphan Impurity D

1453167-99-1
1009119-65-6

Daclatasvir 2HCl

1009119-65-6
6358-64-1

2,5-Dimethoxy-4-chloroaniline

6358-64-1
512-04-9

Diosgenin

512-04-9
334473-41-5

Dihydro Uracil D4

334473-41-5
129938-20-1

Dapoxetine HCl

129938-20-1
83435-67-0

Delapril HCl

83435-67-0
1051375-19-9

Dolutegravir sodium

1051375-19-9
15362-40-0

Diclofenac related compound A

15362-40-0
1195765-45-7

Dabrafenib

1195765-45-7
6294-79-7

Diallyl Isocyanurate

6294-79-7
1177-87-3

21-O-Acetyl Dexamethasone

1177-87-3
10592-13-9

Doxycycline HCl

10592-13-9
150-69-6

Dulcin

150-69-6
80-73-9

1,3-Dimethyl-2-imidazolidinone

80-73-9
141-03-7

Dibutyl Succinate

141-03-7